Ironwood Pharmaceuticals (IRWD) FCF Margin (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted FCF Margin of 4.81% for Q1 2026, down 96.92% sequentially from 156.31% in Q4 2025, and down 4362.0% YoY from 0.11% in Q1 2025.
Ironwood Pharmaceuticals (IRWD) FCF Margin (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported FCF Margin for 17 years, with the latest figure at 4.81% in Q1 2026.
- Quarterly FCF Margin fell 4362.0% year-over-year to 4.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 31.04% (up 636.0% YoY) and the FY2025 annual result came in at 42.89%, up 1346.0% from the prior year.
- FCF Margin retreated to 4.81% in Q1 2026 per IRWD's latest filing, from 156.31% in the prior quarter.
- Over five years, FCF Margin peaked at 156.31% in Q4 2025 and troughed at 17.68% in Q2 2025.
- A 5-year average of 46.38% and a median of 38.98% in 2025 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 13951 bps in 2025, down 5307 bps in 2025.
- Over 5 years, FCF Margin stood at 73.89% in 2022, then sank by 59 bps to 30.3% in 2023, then plunged by 45 bps to 16.8% in 2024, then jumped by 830 bps to 156.31% in 2025, then plunged by 97 bps to 4.81% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 4.81%, 156.31%, and 38.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 667.48 Mn | 588.36 Mn | - | 51.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.55% |
| Mar 31, 2026 | 4.81% |
| Dec 31, 2025 | 156.31% |
| Sep 30, 2025 | 38.98% |
| Jun 30, 2025 | -17.68% |
| Mar 31, 2025 | 48.42% |
| Dec 31, 2024 | 16.80% |
| Sep 30, 2024 | 10.77% |
| Jun 30, 2024 | 35.39% |
| Mar 31, 2024 | 59.99% |
| Dec 31, 2023 | 30.30% |
| Sep 30, 2023 | 28.50% |
| Jun 30, 2023 | 32.56% |
| Mar 31, 2023 | 77.03% |
| Dec 31, 2022 | 73.89% |
| Sep 30, 2022 | 63.54% |
| Jun 30, 2022 | 63.02% |
| Mar 31, 2022 | 65.74% |
| Dec 31, 2021 | 55.02% |
| Sep 30, 2021 | 72.35% |